NCT06489496View on ClinicalTrials.gov

Prostate Cancer 18F-PSMA-1007 PET/CT Access Trial

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2029

Study Completion Date

October 1, 2030

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

18F-1007 PSMA PSMA PET/CT

"Each patient will receive an IV injection 18F-PSMA-1007 PET/CT.~PET/CT Imaging will be conducted beginning 90-120 minutes after an injection of 4 MBq/kg (max 400 MBq +/- 15%) 18F-PSMA-1007 in patients."

All Listed Sponsors
lead

Alberta Health services

OTHER

NCT06489496 - Prostate Cancer 18F-PSMA-1007 PET/CT Access Trial | Biotech Hunter | Biotech Hunter